Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets

Drug Development and Industrial Pharmacy

Volumn 35, Issue 1, 2009, Pages 26-33

  Zhang, Xiong ^a   Tang, Xing ^a   Yang, Rui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Controlled release pellets; Eudragit NE30D; Extrusion spheronization; Similarity factor; Tamsulosin hydrochloride

Indexed keywords

CARBOPOL 974P; EUDRAGIT; LACTOSE; MICROCRYSTALLINE CELLULOSE; TAMSULOSIN;

ARTICLE; CENTRIFUGAL COATER; CONTROLLED RELEASE FORMULATION; DRUG CAPSULE; DRUG COATING; DRUG PELLET; DRUG SOLUBILITY; ENTERIC RELEASE PELLET; EQUIPMENT; FLUIDIZED BED COATER; PELLET EXTRUSION; SPHERONIZATION; SUSTAINED RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION;

ACRYLATES; ADRENERGIC ALPHA-ANTAGONISTS; CAPSULES; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; LACTOSE; METHACRYLATES; MICROSCOPY, ELECTRON, SCANNING; POLYMERS; SOLUBILITY; SULFONAMIDES; TECHNOLOGY, PHARMACEUTICAL;

EID: 56749152339     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802144203     Document Type: Article

References (40)

1. Amighi, K., Timmermans, J., Puigdevall, J., Baltes, E., & Moes, A. J. (1998). Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation. Drug Dev. Ind. Pharm., 24(6), 509-515.
2. Beduschi, M. C., Beduschi, R., & Oesterling, J. E. (1998). Alpha-blockade therapy for benign prostatic hyperplasia: From a nonselective to a more selective alpha1A-adrenergic antagonist. Urology, 51(6), 861-872.
3. Bobmeier, R., Guo, X., & Paeratakul, O. (1997). Process and formulation factors affecting the drug release from pellets coated with the ethylcellulose-pseudolatex aquacoat. In McGinity, J. W. (Ed.), Aqueous polymeric coating for pharmaceutical dosage forms (pp. 55-56). New York: Marcel Dekker.
4. Chapple, C., & Andersson, K. E. (2002). Tamsulosin: An overview. World J. Urol., 19(6), 397-404.
5. Chen, S. J., & Zhu, J. B. (2005). The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method. Yao Xue Xue Bao, 40(7), 606-610.
6. Chen, S., Zhu, J., & Cheng, J. (2007). Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride. Pharmazie, 62(12), 907-913.
7. Costa, P. (2001). An alternative method to the evaluation of similarity factor in dissolution testing. Int. J. Pharm., 220(1-2), 77-83.
8. De Castro, W. V., Pires, M. A., Oliveira, M. A., Vianna-Soares, C. D., Nunan, E. A., Pianetti, G. A., Moreira-Campos, L. M., De Castro, W. V., Mertens-Talcott, S. U., & Derendorf, H. (2006). The influence of formulation on the dissolution profile of diclofenac sodium tablets. Drug Dev. Ind. Pharm., 32(9), 1103-1109.
9. Erkoboni, D. F. (2003). Extrusion/spheronization. In I. Ghebre-Sellassie & C. Martin (Eds.), Pharmaceutical extrusion technology (pp. 277-278). New York: Marcel Dekker.
10. Fujimori, J., Yonemochi, E., Fukuoka, E., & Terada, K. (2002). Application of eudragit RS to thermo-sensitive drug delivery systems. I. Thermo-sensitive drug release from acetaminophen matrix tablets consisting of eudragit RS/PEG 400 blend polymers. Chem. Pharm. Bull. (Tokyo), 50(3), 408-412.
11. Fukumori, Y. (1997). Coating of multiparticulates using polymeric dispersions. In I. Ghebre-Sellasie (Ed.), Multiparticulate oral drug delivery (pp. 79-111). New York: Marcel Dekker.
12. Ghebre-Sellassie, I. (1989). Pellets: A general overview. In I. Ghebre-Sellassie (Ed.), Pharmaceutical pelletization technology (pp. 6-7). New York: Marcel Dekker.
13. Hu, L. D., Liu, Y., Tang, X., & Zhang, Q. (2006). Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Eur. J. Pharm. Biopharm., 64(2), 185-192.
14. Kim, M. S., Jun, S. W., Lee, S., Lee, T. W., Park, J. S., & Hwang, S. J. (2005). The influence of surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form. J. Pharm. Pharmacol., 57(6), 735-742.
15. Kim, M. S., Kim, J. S., & Hwang, S. J. (2007). The effect of sodium alginate on physical and dissolution properties of surelease-matrix pellets prepared by a novel pelletizer. Chem. Pharm. Bull. (Tokyo), 55(11), 1631-1634.
16. Kim, M. S., Kim, J. S., Kang, S. H., Yoo, Y. H., Lee, S., Park, J. S., Woo, J. S., & Hwang, S. J. (2007). Influence of water soluble additives and HPMCP on drug release from Surelease-coated pellets containing tamsulosin hydrochloride. Arch. Pharm. Res., 30(8), 1008-1013.
17. Kim, M. S., Kim, J. S., Lee, S., Jun, S. W., Park, J. S., Woo, J. S., & Hwang, S. J. (2006). Optimization of tamsulosin hydrochloride controlled release pellets coated with Surelease and neutralized HPMCP. J. Pharm. Pharmacol., 58(12), 1611-1616.
18. Kim, J. S., Kim, M. S., Park, H. J., Lee, S., Park, J. S., & Hwang, S. J. (2007). Statistical optimization of tamsulosin hydrochloride controlled release pellets coated with the blend of HPMCP and HPMC. Chem. Pharm. Bull., 55(6), 936-939.
19. Kim, M. S., Kim, J. S., You, Y. H., Park, H. J., Lee, S., Park, J. S., Woo, J. S., & Hwang, S. J. (2007). Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology. Int. J. Pharm., 341(1-2), 97-104.
20. Kim, M. S., Park, G. D., Jun, S. W., Lee, S., Park, J. S., & Hwang, S. J. (2005). Controlled release tamsulosin hydrochloride from alginate beads with waxy materials. J. Pharm. Pharmacol., 57(12), 1521-1528.
21. Lecomte, F., Siepmann, J., Walther, M., MacRae, R. J., & Bodmeier, R. (2003). Blends of enteric and GIT-insoluble polymers used for film coating: Physicochemical characterization and drug release patterns. J. Control. Release, 89(3), 457-471.
22. Lecomte, F., Siepmann, J., Walther, M., MacRae, R. J., & Bodmeier, R. (2004). Polymer blends used for the coating of multiparticulates: Comparison of aqueous and organic coating techniques. Pharm. Res., 21(5), 882-890.
23. Lehmann, K. (1997). Chemistry and application properties of polymethacrylate coating systems. In J. W. McGinity (Ed.), Aqueous polymeric coatings for pharmaceutical dosage forms (pp. 101-176). New York, Basel, Hong Kong: Marcel Dekker.
24. Ma, M. C., Wang, B. B., Liu, J. P., & Tsong, Y. (2000). Assessment of similarity between dissolution profiles. J. Biopharm. Stat., 10(2), 229-249.
25. Maganti, L., & Çelik, M. (1994). Compaction studies on pellets: II. Coated pellets. Int. J. Pharm., 103, 55-67.
26. Marucci, M., Ragnarsson, G., & Axelsson, A. (2007). Evaluation of osmotic effects on coated pellets using a mechanistic model. Int. J. Pharm., 336(1), 67-74.
27. Moore, J. W., & Flanner, H. H. (1996). Mathematical comparison of dissolution profiles. Pharm. Technol., 20, 64-75.
28. Munday, D. L. (2003). Film coated pellets containing verapamil hydrochloride: Enhanced dissolution into neutral medium. Drug Dev. Ind. Pharm., 29, 575-583.
29. Neau, S. H., Chow, M. Y., Hileman, G. A., Durrani, M. J., Gheyas, F., & Evans, B. A. (2000). Formulation and process considerations for beads containing Carbopol 974p, NF resin made by extrusion-spheronization. Int. J. Pharm., 199(2), 129-140.
30. O'Leary, M. P. (2001). Tamsulosin: Current clinical experience. Urology, 58(6), 42-48.
31. Polli, J. E., Rekhi, G. S., Augsburger, L. L., & Shah, V. P. (1997). Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci., 86(6), 690-700.
32. Porter, S. C. (2006). Scale-up of film coating. In M. Levin (Ed.), Pharmaceutical process scale-up (pp. 435-440). New York, London: Taylor & Francis.
33. Reynolds, A. D. (1970). A new technique for the production of spherical particles. Manuf. Chem. Aerosol News, 41, 40-43.
34. Sakellariou, P., Rowe, R. C., & White, E. F. C. (1986). Polymer/polymer interaction in blends of ethyl cellulose with both cellulose derivatives and polyethylene glycol 6000. Int. J. Pharm., 34, 93-103.
35. Shah, V. P., Tsong, Y., Sathe, P., & Liu, J. P. (1998). In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm. Res., 15(6), 889-896.
36. Siepmann, F., Siepmann, J., Walther, M., MacRae, R. J., & Bodmeier, R. (2008). Polymer blends for controlled release coatings. J. Control. Release, 125(1), 1-15.
37. Trivedi, N. R., Rajan, M. G., Johnson, J. R., & Shukla, A. J. (2007). Pharmaceutical approaches to preparing pelletized dosage forms using the extrusion-spheronization process. Crit. Rev. Ther. Drug Carrier Syst., 24(1), 1-40.
38. Williams, R. O., III, & Liu, J. (2000). Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate. Eur. J. Pharm. Biopharm., 49(3), 243-252.
39. Wong, D., & Bodmeier, R. (1996). Flocculation of an aqueous colloidal ethyl cellulose dispersion (Aquacoat) with a water-soluble polymer, hydroxypropyl methylcellulose. Eur. J. Pharm. Biopharm., 42, 12-15.
40. Zheng, W., & McGinity, J. W. (2003). Influence of Eudragit NE 30 D blended with Eudragit L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets. Drug Dev. Ind. Pharm., 29(3), 357-366.